COPENHAGEN, DK. and BOSTON, MASS. — Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center (BIDMC) today announced they have signed a collaborative agreement to…

Ferring announced today that it will collaborate with Ortho-McNeil Pharmaceuticals Inc. (Ortho-McNeil) and Ortho-McNeil’s research affiliate, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)…

The Board of Directors of Ferring announced this week that Professor Michael Rosenblatt has been appointed to the Group Board…

Ferring would like to announce that Mr. Aaron Graff has been appointed as Vice President of Global Marketing, Medical Services and Business Development…

Ferring Launches a New No Needle Device at 2nd Ferring International Paediatric Endocrinology Symposium…

The Board of Directors of Ferring announced today that Mr. Bernd Wolff has been appointed as a board member. Wolff becomes an outside director to the board…

Ferring Pharmaceuticals, a world leader in naturally occurring protein hormones, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Bravelle™…

The new Ferring International Center in Copenhagen will be officially inaugurated by the Danish Minister for Science, Technology and Innovation and renowned architect Henning Larsen on Thursday, March 21st, 2002…

International infertility experts convened at a congress today to preview the newest scientific findings in infertility and to discuss better ways to meet increasing demands from infertile couples for more effective treatments…